164 related articles for article (PubMed ID: 32994281)
1. Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma.
Potjer TP; van der Grinten TWJ; Lakeman IMM; Bollen SH; Rodríguez-Girondo M; Iles MM; Barrett JH; Kiemeney LA; Gruis NA; van Asperen CJ; van der Stoep N
J Med Genet; 2021 Nov; 58(11):760-766. PubMed ID: 32994281
[TBL] [Abstract][Full Text] [Related]
2. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
[TBL] [Abstract][Full Text] [Related]
3. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
4. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.
Gu F; Chen TH; Pfeiffer RM; Fargnoli MC; Calista D; Ghiorzo P; Peris K; Puig S; Menin C; De Nicolo A; Rodolfo M; Pellegrini C; Pastorino L; Evangelou E; Zhang T; Hua X; DellaValle CT; Timothy Bishop D; MacGregor S; Iles MI; Law MH; Cust A; Brown KM; Stratigos AJ; Nagore E; Chanock S; Shi J; Consortium MM; Consortium M; Landi MT
Hum Mol Genet; 2018 Dec; 27(23):4145-4156. PubMed ID: 30060076
[TBL] [Abstract][Full Text] [Related]
5. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
6. [Molecular biology of familial cases of human melanoma].
Kit OI; Vodolazhsky DL; Timoshkina NN; Przhedetsky YV; Khokhlova OV
Vopr Onkol; 2015; 61(6):889-97. PubMed ID: 26995975
[TBL] [Abstract][Full Text] [Related]
7. Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).
Visser M; van der Stoep N; Gruis N
Fam Cancer; 2019 Apr; 18(2):267-271. PubMed ID: 30659395
[No Abstract] [Full Text] [Related]
8. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting.
Seviiri M; Scolyer RA; Bishop DT; Newton-Bishop JA; Iles MM; Lo SN; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Gordon SD; Olsen CM; Whiteman DC; Landi MT; Thompson JF; Long GV; MacGregor S; Law MH
J Transl Med; 2022 Sep; 20(1):403. PubMed ID: 36064556
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
[TBL] [Abstract][Full Text] [Related]
10. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Yokoyama S; Woods SL; Boyle GM; Aoude LG; MacGregor S; Zismann V; Gartside M; Cust AE; Haq R; Harland M; Taylor JC; Duffy DL; Holohan K; Dutton-Regester K; Palmer JM; Bonazzi V; Stark MS; Symmons J; Law MH; Schmidt C; Lanagan C; O'Connor L; Holland EA; Schmid H; Maskiell JA; Jetann J; Ferguson M; Jenkins MA; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Whiteman DC; Pharoah PD; Easton DF; Dunning AM; Newton-Bishop JA; Montgomery GW; Martin NG; Mann GJ; Bishop DT; Tsao H; Trent JM; Fisher DE; Hayward NK; Brown KM
Nature; 2011 Nov; 480(7375):99-103. PubMed ID: 22080950
[TBL] [Abstract][Full Text] [Related]
11. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.
Jannot AS; Meziani R; Bertrand G; Gérard B; Descamps V; Archimbaud A; Picard C; Ollivaud L; Basset-Seguin N; Kerob D; Lanternier G; Lebbe C; Saiag P; Crickx B; Clerget-Darpoux F; Grandchamp B; Soufir N; Melan-Cohort
Eur J Hum Genet; 2005 Aug; 13(8):913-20. PubMed ID: 15889046
[TBL] [Abstract][Full Text] [Related]
12. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
14. Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.
Bakshi A; Yan M; Riaz M; Polekhina G; Orchard SG; Tiller J; Wolfe R; Joshi A; Cao Y; McInerney-Leo AM; Yanes T; Janda M; Soyer HP; Cust AE; Law MH; Gibbs P; McLean C; Chan AT; McNeil JJ; Mar VJ; Lacaze P
J Natl Cancer Inst; 2021 Oct; 113(10):1379-1385. PubMed ID: 33837773
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
Bruno W; Pastorino L; Ghiorzo P; Andreotti V; Martinuzzi C; Menin C; Elefanti L; Stagni C; Vecchiato A; Rodolfo M; Maurichi A; Manoukian S; De Giorgi V; Savarese I; Gensini F; Borgognoni L; Testori A; Spadola G; Mandalà M; Imberti G; Savoia P; Astrua C; Ronco AM; Farnetti A; Tibiletti MG; Lombardo M; Palmieri G; Ayala F; Ascierto P; Ghigliotti G; Muggianu M; Spagnolo F; Picasso V; Tanda ET; Queirolo P; Bianchi-Scarrà G
J Am Acad Dermatol; 2016 Feb; 74(2):325-32. PubMed ID: 26775776
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.
Delaunay J; Martin L; Bressac-de Paillerets B; Duru G; Ingster O; Thomas L
JAMA Dermatol; 2017 Nov; 153(11):1122-1129. PubMed ID: 28903138
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
19. Joint effect of multiple common SNPs predicts melanoma susceptibility.
Fang S; Han J; Zhang M; Wang LE; Wei Q; Amos CI; Lee JE
PLoS One; 2013; 8(12):e85642. PubMed ID: 24392023
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
